Effects of teriparatide versus risedronate following pertrochanteric fracture fixation
How to Cite
OrthoEvidence. Effects of teriparatide versus risedronate following pertrochanteric fracture fixation. ACE Report. 2017;6(10):19. Available from: https://myorthoevidence.com/AceReport/Report/9418
Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 WeeksJ Bone Joint Surg Am. 2016 Nov 16;98(22):1868-1878
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
224 patients over the age of 50 with a pertrochanteric hip fracture who had undergone fixation were randomized to 26 weeks of daily subcutaneous teriparatide 20ug or weekly oral risedronate 35mg. The purpose of this study was to compare measures of functional and clinical outcome, as well as safety outcomes and fracture healing over a 26-week follow-up. Results demonstrated significantly better Ti...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE